Codexis (CDXS) Cash from Financing Activities (2010 - 2026)

Codexis' (CDXS) quarterly Cash from Financing Activities came in at -$14000.0 in Q1 2026, down 101.29% year-on-year from $1.1 million in Q1 2025, and down 107.78% quarter-over-quarter from $180000.0 in Q4 2025.

Codexis (CDXS) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Codexis' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$14000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 101.29% year-over-year to -$14000.0 in Q1 2026; TTM through Mar 2026 was $26.8 million, a 17.0% decrease from a year earlier, with the FY2025 full-year figure at $27.9 million, down 53.85% from the prior year.
  • Cash from Financing Activities eased to -$14000.0 in Q1 2026 per CDXS's latest filing, from $180000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $30.3 million in Q3 2024 and bottomed at -$1.3 million in Q1 2022.
  • The 5-year median for Cash from Financing Activities is $286000.0 (2022), against an average of $6.0 million.
  • Across the five-year window, Cash from Financing Activities plunged 7629.41% in 2022 and soared 28161.11% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $339000.0 in 2022, then slumped by 131.86% to -$108000.0 in 2023, then surged by 1148.15% to $1.1 million in 2024, then tumbled by 84.1% to $180000.0 in 2025, then tumbled by 107.78% to -$14000.0 in 2026.
  • Per Business Quant, the three latest CDXS Cash from Financing Activities figures stand at -$14000.0 (Q1 2026), $180000.0 (Q4 2025), and -$111000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Codexis 180.63 Mn 115.49 Mn 13.18 Mn -14,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -14,000.00
Mar 31, 2026 -14,000.00
Dec 31, 2025 180,000.00
Dec 31, 2025 180,000.00
Sep 30, 2025 -111,000.00
Sep 30, 2025 -111,000.00
Jun 30, 2025 26.77 Mn
Jun 30, 2025 26.77 Mn
Mar 31, 2025 1.09 Mn
Mar 31, 2025 1.09 Mn
Dec 31, 2024 1.13 Mn
Dec 31, 2024 1.13 Mn
Sep 30, 2024 30.31 Mn
Sep 30, 2024 30.31 Mn
Jun 30, 2024 -197,000.00
Jun 30, 2024 -197,000.00
Mar 31, 2024 29.28 Mn
Mar 31, 2024 29.28 Mn
Sep 30, 2023 -108,000.00
Sep 30, 2023 -108,000.00